• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肺动脉高压患者的心脏住院情况:2001 年至 2014 年的趋势和结果。

Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014.

机构信息

Department of Internal Medicine, Yale University School of Medicine, P.O. Box 208030, New Haven, CT, 06520, USA.

Actelion Clinical Research, Allschwil, Switzerland.

出版信息

Respir Med. 2020 Jan;161:105850. doi: 10.1016/j.rmed.2019.105850. Epub 2019 Nov 28.

DOI:10.1016/j.rmed.2019.105850
PMID:32056724
Abstract

BACKGROUND

Hospitalizations in pulmonary arterial hypertension (PAH) are common and are often for cardiac conditions. Using the National (Nationwide) Inpatient Sample (NIS), we examined characteristics and mortality of primary cardiac hospitalizations in PAH from 2001 to 2014.

METHODS

Adult hospitalizations with any diagnosis code for PAH were identified. Primary cardiac disease was defined as a primary discharge diagnosis of congestive heart failure (CHF), pulmonary heart disease, coronary atherosclerosis, acute myocardial infarction, dysrhythmia, conduction disorder, cardiomyopathy or carditis, heart valve disorder, or cardiac arrest. Temporal trends, characteristics, and in-hospital mortality were analyzed.

RESULTS

From 2001 to 2014, there were 207,095 hospitalizations in PAH, of which 100,509 (48.5%) carried a primary cardiac diagnosis. Most primary cardiac hospitalizations in PAH were for CHF, and pneumonia was the most common primary non-cardiac diagnosis. Over the study period, primary cardiac hospitalizations in PAH fell from 52.9% to 41.4% (p < 0.001). CHF was the most frequent primary cardiac diagnosis associated with death, with sepsis representing the most common primary non-cardiac disease (1,226; 25.0%). Overall, the mortality in primary cardiac hospitalizations in PAH was 5.3% (vs. in primary non-cardiac, 6.9%, p < 0.001). On multivariable analysis, a primary cardiac discharge diagnosis remained associated with a decreased risk of death (odds ratio 0.85, p = 0.010).

CONCLUSION

Primary cardiac hospitalizations in PAH are common and are associated with decreased mortality compared to admissions for primary non-cardiac diagnoses.

摘要

背景

肺动脉高压(PAH)患者常因心脏疾病住院。本研究利用全国住院患者样本(NIS),分析了 2001 年至 2014 年 PAH 患者因原发性心脏疾病住院的特征和死亡率。

方法

确定任何诊断代码为 PAH 的成人住院患者。将原发性心脏疾病定义为充血性心力衰竭(CHF)、肺心病、冠状动脉粥样硬化、急性心肌梗死、心律失常、传导障碍、心肌病或心肌炎、心脏瓣膜疾病或心脏骤停的主要出院诊断。分析了时间趋势、特征和住院死亡率。

结果

2001 年至 2014 年,PAH 住院患者 207095 例,其中 100509 例(48.5%)携带原发性心脏诊断。PAH 中大多数原发性心脏住院是由 CHF 引起的,肺炎是最常见的原发性非心脏诊断。在研究期间,PAH 中的原发性心脏住院比例从 52.9%降至 41.4%(p<0.001)。CHF 是与死亡相关的最常见原发性心脏诊断,败血症是最常见的原发性非心脏疾病(1226 例;25.0%)。总体而言,PAH 原发性心脏住院患者的死亡率为 5.3%(而原发性非心脏疾病为 6.9%,p<0.001)。多变量分析显示,主要心脏出院诊断与死亡风险降低相关(比值比 0.85,p=0.010)。

结论

PAH 患者因原发性心脏疾病住院很常见,与因原发性非心脏疾病住院相比,死亡率较低。

相似文献

1
Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014.原发性肺动脉高压患者的心脏住院情况:2001 年至 2014 年的趋势和结果。
Respir Med. 2020 Jan;161:105850. doi: 10.1016/j.rmed.2019.105850. Epub 2019 Nov 28.
2
Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.美国肺动脉高压相关住院治疗的趋势与结果:对2001年至2012年全国住院患者样本数据库的分析
JAMA Cardiol. 2016 Dec 1;1(9):1021-1029. doi: 10.1001/jamacardio.2016.3591.
3
National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations - Analysis of the National Inpatient Sample Database.全国肺动脉高压相关住院患者的趋势和住院结局——基于全国住院患者样本数据库的分析。
Int J Cardiol. 2020 Nov 15;319:131-138. doi: 10.1016/j.ijcard.2020.06.036. Epub 2020 Jun 27.
4
Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.系统性硬皮病中的肺动脉高压:一项全国性住院患者分析。
ARP Rheumatol. 2024 Apr-Jun;3(2):95-100.
5
Hospital outcomes for patients with pulmonary arterial hypertension in sepsis and septic shock.脓毒症和感染性休克患者的肺动脉高压的医院转归。
BMC Pulm Med. 2022 Oct 3;22(1):374. doi: 10.1186/s12890-022-02145-1.
6
Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.对医疗保险优势计划参保者或商业保险覆盖的肺动脉高压患者的肺动脉高压相关住院费用进行特征分析:一项回顾性数据库研究。
Am J Manag Care. 2015 Jan;21(3 Suppl):s47-58.
7
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States.娱乐性大麻使用者的住院和手术主要原因、院内死亡率预测因素以及心血管和脑血管事件趋势:美国一项为期五年的全国性住院患者评估
Cureus. 2018 Aug 23;10(8):e3195. doi: 10.7759/cureus.3195.
8
Effect of macitentan on hospitalizations: results from the SERAPHIN trial.马西替坦对住院的影响:SERAPHIN 试验的结果。
JACC Heart Fail. 2015 Jan;3(1):1-8. doi: 10.1016/j.jchf.2014.07.013. Epub 2014 Nov 11.
9
Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014.2000 年至 2014 年美国遗传性出血性毛细血管扩张症伴肺动脉高压住院治疗情况。
Respir Med. 2019 Feb;147:26-30. doi: 10.1016/j.rmed.2018.12.013. Epub 2019 Jan 2.
10
Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States.美国肝移植术后心血管疾病的住院治疗情况。
Liver Transpl. 2018 Oct;24(10):1398-1410. doi: 10.1002/lt.25055.

引用本文的文献

1
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications.协调细胞间对话:解析细胞外囊泡在呼吸系统细胞间通讯中的重要作用。
Eur Respir Rev. 2024 Nov 13;33(174). doi: 10.1183/16000617.0272-2023. Print 2024 Oct.
2
Management and outcomes in pulmonary arterial hypertension patients with sepsis.肺动脉高压合并脓毒症患者的管理和结局。
BMC Pulm Med. 2024 Oct 28;24(1):538. doi: 10.1186/s12890-024-03355-5.
3
Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil.
巴西新冠疫情期间的肺动脉高压治疗结果
J Bras Pneumol. 2023 Nov 17;49(5):e20230020. doi: 10.36416/1806-3756/e20230020.
4
Effects of Hormone Replacement Therapy on Women's Lung Health and Disease.激素替代疗法对女性肺部健康与疾病的影响。
Pulm Ther. 2023 Dec;9(4):461-477. doi: 10.1007/s41030-023-00240-0. Epub 2023 Oct 10.
5
Role of macrophages in pulmonary arterial hypertension.巨噬细胞在肺动脉高压中的作用。
Front Immunol. 2023 Apr 19;14:1152881. doi: 10.3389/fimmu.2023.1152881. eCollection 2023.
6
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.COVID-19 患者的肺动脉高压管理。
Heart Fail Clin. 2023 Jan;19(1):107-114. doi: 10.1016/j.hfc.2022.07.003. Epub 2022 Aug 10.
7
Successful Management of Coronavirus Disease 2019-Related Respiratory Failure Using High-Flow Nasal Cannula Therapy in a Patient with Underlying Pulmonary Artery Hypertension.高流量鼻导管治疗成功管理一例合并肺动脉高压的2019冠状病毒病相关呼吸衰竭患者
Case Rep Pulmonol. 2022 Nov 9;2022:1774796. doi: 10.1155/2022/1774796. eCollection 2022.
8
The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?2019冠状病毒病大流行对肺动脉高压的影响:我们学到了什么?
Pulm Circ. 2022 Oct 1;12(4):e12142. doi: 10.1002/pul2.12142. eCollection 2022 Oct.
9
Hospital outcomes for patients with pulmonary arterial hypertension in sepsis and septic shock.脓毒症和感染性休克患者的肺动脉高压的医院转归。
BMC Pulm Med. 2022 Oct 3;22(1):374. doi: 10.1186/s12890-022-02145-1.
10
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City.肺动脉高压(PAH)患者中的新型冠状病毒肺炎(COVID-19):来自纽约市一家大型PAH中心的观察结果
Diagnostics (Basel). 2021 Jan 15;11(1):128. doi: 10.3390/diagnostics11010128.